CTSO

Cytosorbents Corp. is a medical device company focused on critical care therapies. Headquartered in Monmouth Junction, New Jersey, the company develops and markets blood purification technologies. Its flagship product, CytoSorb, is designed to reduce cytokine levels in the bloodstream during severe inflammatory conditions such as sepsis and cardiac surgery. The device is approved and used in multiple countries, particularly in Europe, for treating critically ill patients.